[{"Assets_0_Q1_USD":444845000.0,"CommonStockSharesOutstanding_0_Q1_shares":29943768.0,"NetIncomeLoss_1_Q1_USD":-17713000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":87635000.0,"StockholdersEquity_0_Q1_USD":242622000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":29836277.0,"Ticker":"NVRO","CIK":"1444380","name":"NEVRO CORP","OfficialName":"Nevro Corp. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2648227724.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NYSE","SP500":"nan","filed":"20180507"}]